Diagnostic impact of promoter methylation and E-cadherin gene and protein expression levels in laryngeal carcinoma. - Wikidata - wikimedia - TriplyDB

Diagnostic impact of promoter methylation and E-cadherin gene and protein expression levels in laryngeal carcinoma.

Diagnostic impact of promoter methylation and E-cadherin gene and protein expression levels in laryngeal carcinoma.

http://www.wikidata.org/entity/Q37601968

about

Expression of cell adhesion molecules in laryngeal carcinoma - preliminary analysis.Deregulation of ARID1A, CDH1, cMET and PIK3CA and target-related microRNA expression in gastric cancer.The Clinical Signification of Claudin-11 Promoter Hypermethylation for Laryngeal Squamous Cell Carcinoma.

P2860

Q35165583-73D7FFF3-672C-45B7-A6B2-10F9A94C7D5C Q36413660-C8226A5E-4C0D-4AB8-961B-D849A8A27593 Q41231334-EF384072-4B88-4AE7-A7AB-DDA3B129C2C5

P2860

Diagnostic impact of promoter methylation and E-cadherin gene and protein expression levels in laryngeal carcinoma.

http://www.wikidata.org/entity/Q37601968

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 28 June 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Diagnostic impact of promoter ...... levels in laryngeal carcinoma.

@en

Diagnostic impact of promoter ...... levels in laryngeal carcinoma.

@nl

type

label

Diagnostic impact of promoter ...... levels in laryngeal carcinoma.

@en

Diagnostic impact of promoter ...... levels in laryngeal carcinoma.

@nl

prefLabel

Diagnostic impact of promoter ...... levels in laryngeal carcinoma.

@en

Diagnostic impact of promoter ...... levels in laryngeal carcinoma.

@nl

P1433

Q37601968-88C88D4E-8523-47D4-8B74-55A9872502E2

P1476

Q37601968-C27A563C-9E02-4E49-A877-7AC7BAF5A35B

P2093

Q37601968-05C74424-53E8-4044-A1D4-F7AFF99449EA

Q37601968-2575B4D7-2466-43B1-9862-643B15D0B3B9

Q37601968-71D883A8-E036-46F9-AC35-7C54B4BAF69A

Q37601968-E98A1772-3267-46BD-8A90-C1A6F30D8302

P2860

Q37601968-00C94550-5992-4C53-B313-4FF1D6B5E31B

Q37601968-01C8D15C-899D-46E3-A503-02FD9CFA301C

Q37601968-17766501-0079-4EF7-B193-A3C039ED3616

Q37601968-2C4D2B47-FFEE-4F0E-B4EE-F22E91FBAC30

Q37601968-2D0EF076-5640-4D27-A577-F22F36308138

Q37601968-301B3B51-5F7D-474F-B7FE-C03E2CDBBB1D

Q37601968-33EE9DBE-4805-44EE-A9A4-4431CC17DF22

Q37601968-36DB8D1E-4C4F-4CCB-B290-C238DDA27D38

Q37601968-45454638-B763-431F-8375-E639215CD8D5

Q37601968-45D7BBEA-B3F2-4B8E-BB32-6F90C83A26E6

P304

Q37601968-90B050CE-4375-4E19-BB22-D83514D71F98

P31

Q37601968-7C559D4F-EECB-46F1-81E0-9C1DC7B31C82

P356

Q37601968-190D7D1B-BDF2-430C-89FB-E1E54202BA96

P433

Q37601968-C378B7D7-8C4F-42B9-BF97-B45A0A008966

P478

Q37601968-E69D88BD-FB20-473F-9362-DBEF6B564B84

P50

Q37601968-2B277CEB-C78B-4216-8C83-5F506E152A16

Q37601968-732782FB-DCC0-4B8E-8901-BA9E3604D929

P577

Q37601968-8D15E71C-725F-4802-8280-D86238EE8555

P5875

Q37601968-40ECD1C0-B01D-4FCC-928A-216749A7A54B

P698

Q37601968-44D8BF53-E0A3-425E-8D0C-0C80F76CFD47

P921

Q37601968-46BE1D5B-C2F7-4FAC-A4B6-73A1D17DAA6E

Q37601968-545f4086-02d5-438c-91ae-aeb5d5192b5c

P932

Q37601968-47D0B7A8-0780-430C-AB76-65F5E190C0D9

P356

P1433

Contemporary oncology

P1476

Diagnostic impact of promoter ...... levels in laryngeal carcinoma.

@en

P2093

Iwona Lewy-Trenda

http://www.w3.org/2001/XMLSchema#string

Jan Woś

http://www.w3.org/2001/XMLSchema#string

Katarzyna Starska

http://www.w3.org/2001/XMLSchema#string

Paweł Papież

http://www.w3.org/2001/XMLSchema#string

P2860

In breast carcinoma dysadherin expression is correlated with invasiveness but not with E-cadherin

Autoregulation of E-cadherin expression by cadherin-cadherin interactions: the roles of beta-catenin signaling, Slug, and MAPK

Cleavage of structural proteins during the assembly of the head of bacteriophage T4

Balancing cell adhesion and Wnt signaling, the key role of beta-catenin

CDH1 promoter hypermethylation and E-cadherin protein expression in infiltrating breast cancer.

E-cadherin as an indicator of mesenchymal to epithelial reverting transitions during the metastatic seeding of disseminated carcinomas.

E-cadherin promotor methylation and mutation are inversely related to motility capacity of breast cancer cells.

New TNM staging criteria for head and neck tumors.

Real time PCR analyses of expression of E-cadherin, alpha-, beta- and gamma-catenin in human breast cancer for predicting clinical outcome.

Inhibition of Akt activity induces the mesenchymal-to-epithelial reverting transition with restoring E-cadherin expression in KB and KOSCC-25B oral squamous cell carcinoma cells

P304

263-271

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.5114/WO.2013.35284

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

17

http://www.w3.org/2001/XMLSchema#string

P50

Magdalena Bryś

P577

2013-06-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

260528896

http://www.w3.org/2001/XMLSchema#string

P698

24596512

http://www.w3.org/2001/XMLSchema#string

P921

P932

3934075

http://www.w3.org/2001/XMLSchema#string